Worldwide, birth outcomes have improved dramatically over the past 40 years, yet there is still a large gap in birth outcomes between developing and industrialized countries. Within industrialized countries, genetic disorders and other birth defects are a principal cause of infant mortality. As infant mortality rates continue to decline as expected in developing countries, the contribution of genetic disorders and other birth defects to overall mortality and disability in their populations will approach and, for many, exceed that seen in high income countries. Cost-effective opportunities exist to reduce poor birth outcomes attributable to genetic disorders and other birth defects and to promote health, education, and community services for the families of children born with these conditions. We will present the results of an Institute of Medicine study on the global toll of genetic disorders and other birth defects, that was supported in part by the March of Dimes, CDC, NIH, and USAID. The presentation will highlight the report's conclusions and recommendations for prevention, capacity building, and research.
Learning Objectives: Participants will learn about the global human and economic costs of genetic disorders and other birth defects, and their increasing importance, as developing countries reduce infant mortality from infectious diseases and other causes. At the conclusion of the session, participants will understand the nature of the problem, the potential for cost-effective solutions and how to apply them.
Keywords: Birth Defects, Developing Countries
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: N/A
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.